Почетна › ХОБП › Пенсилванија › Philadelphia
Kliničke studije za ХОБП u gradu Philadelphia, PA
26 studija za ХОБП traži učesnike na lokacijama u gradu Philadelphia i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Тражи се учесник
- Temple University - Temple Lung Center, Philadelphia
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Тражи се учесник
- Temple University Hospital, Philadelphia
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Тражи се учесникФаза 2
- DM Clinical Research - Philadelphia, Philadelphia
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 2
- Research Site, Philadelphia
- Research Site, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Тражи се учесникФаза 3
- Suburban Research Associates - Media- Site Number : 8400143, Media · 12 ми удаљено
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 2/3
- Temple University Hospital, Philadelphia
- Temple Health Oaks, Phoenixville · 22 ми удаљено
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Тражи се учесник
- Temple University, Philadelphia
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Тражи се учесникФаза 3
- Temple University Hospital- Site Number : 8400059, Philadelphia
STRIVE Post-Market Registry Study
Тражи се учесникОпсервациона студија
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Тражи се учесникФаза 3
- Research Site, Horsham · 16 ми удаљено
- Research Site, Wilmington · 25 ми удаљено
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Тражи се учесникФаза 3
- GSK Investigational Site, Philadelphia
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Тражи се учесникФаза 3
- GSK Investigational Site, Wilmington · 25 ми удаљено
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Тражи се учесникФаза 3
- Research Site, Philadelphia
- Research Site, Philadelphia
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Тражи се учесник
- Penn Medicine, Philadelphia
- Temple University, Philadelphia
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Тражи се учесникФаза 2
- Temple University, Philadelphia
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Тражи се учесникФаза 3
- Research Site, Philadelphia
COPD Exacerbation Follow Up
Тражи се учесникОпсервациона студија
- Thomas Jefferson University, Philadelphia
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Тражи се учесникФаза 3
- GSK Investigational Site, West Chester · 24 ми удаљено
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Тражи се учесник
- Temple University Hospital, Philadelphia
SPIROMICS Study of Early COPD Progression (SOURCE)
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Temple University, Philadelphia
Feasibility of Semaglutide in Advanced Lung Disease
Тражи се учесникФаза 1/2
- University of Pennsylvania Perelman School of Medicine, Philadelphia
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
Тражи се учесникОпсервациона студија
- Thomas Jefferson University, Philadelphia
Supporting Evidence-based Responses to Emotional Needs in Emphysema
Тражи се учесник
- University of Pennsylvania, Philadelphia
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Тражи се учесникОпсервациона студија
- Temple University, Philadelphia
Temple Health Chest Initiative (THCI 2.0)
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Temple University Of the Commonwealth System of Higher Education, Philadelphia
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Тражи се учесник
- Jeanes Hospital, Philadelphia
- Temple University, Philadelphia
Studije za ХОБП u drugim gradovima
- Miami, FL20 студија
- Houston, TX18 студија
- Birmingham, AL17 студија
- Baltimore, MD16 студија
- Boston, MA15 студија
- Orlando, FL15 студија
- Chicago, IL15 студија
- Dallas, TX13 студија
- New York City, NY12 студија
- Pittsburgh, PA11 студија
- Winston-Salem, NC11 студија
- Hialeah, FL10 студија
Ostale studije u gradu Philadelphia
- Рак (све врсте)57 студија
- Рак дојке51 студија
- Немалоклетни карцином плућа49 студија
- Рак јајника47 студија
- Метастатски карцином42 студија
- Колоректални карцином41 студија
- Рак простате41 студија
- Рак плућа36 студија
- Akutna mijeloidna leukemija33 студија
- Затајење срца31 студија
- Карцином ендометријума29 студија
- Рак панкреаса26 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.